Lymphoma Clinical Trials in Washington

Showing 161-161 of 161 trials

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

NCT00039156

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BAY 59-8862 in treating patients who have refractory non-Hodgkin's lymphoma.

Lymphoma

TheradexStarted Jan 2002

Miami Beach, Florida, United States • Chicago, Illinois, United States • Shreveport, Louisiana, United States +12 more locations

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Lymphoma Trials in Other Cities

Other Conditions in Washington